The Role of LDHAL6B in Tumors, Liver Diseases, Heart Disease and Neurological Diseases

Target Name: LDHAL6B

NCBI ID: G92483

LDHAL6B

The Role of LDHAL6B in Tumors, Liver Diseases, Heart Disease and Neurological Diseases

L-basophil costimulation (LDHAL6B) is an important biomolecule that plays an important role in a variety of physiological and pathological processes. LDHAL6B is a glycoprotein composed of multiple subunits, including 伪, 尾, 纬 and 未 chains. Among them, 伪 and 尾 chains are widely distributed in the extracellular region, while 纬 and 未 chains are mainly distributed within the cell. LDHAL6B plays an important role in a variety of diseases, such as tumors, liver diseases, heart disease, and neurological diseases.

The role of LDHAL6B in tumors

The role of LDHAL6B in tumors has been extensively studied. Many studies have shown that LDHAL6B plays an important role in tumor occurrence and development. For example, studies have shown that the expression level of LDHAL6B is positively correlated with tumor invasion and metastasis. In addition, some studies have also shown that the expression level of LDHAL6B is negatively correlated with the survival rate of tumor patients.

The role of LDHAL6B in liver disease

The role of LDHAL6B in liver disease has also been extensively studied. Many studies have shown that LDHAL6B plays an important role in liver cell injury and regeneration. For example, studies have shown that the expression level of LDHAL6B is positively correlated with the degree of liver cell damage and the regeneration ability of liver cells. In addition, some studies have also shown that the expression level of LDHAL6B is positively correlated with the risk of cirrhosis and liver cancer.

The role of LDHAL6B in heart disease

The role of LDHAL6B in heart disease has also been extensively studied. Many studies have shown that LDHAL6B plays an important role in myocardial injury and regeneration. For example, studies have shown that the expression level of LDHAL6B is positively correlated with the degree of myocardial damage and myocardial regeneration capacity. In addition, some studies have also shown that the expression level of LDHAL6B is negatively correlated with the survival rate of patients with heart disease.

The role of LDHAL6B in neurological diseases

The role of LDHAL6B in neurological diseases has also been extensively studied. Many studies have shown that LDHAL6B plays an important role in neuronal injury and regeneration. For example, studies have shown that the expression level of LDHAL6B is positively correlated with the degree of neuronal damage and the ability of neuronal regeneration. In addition, some studies have also shown that the expression level of LDHAL6B is positively correlated with the risk of neurological diseases.

Biological functions of LDHAL6B

LDHAL6B plays an important role in a variety of physiological and pathological processes. Its biological functions mainly include the following aspects:

1. Signal transduction: LDHAL6B can serve as an intracellular signal transduction molecule and participate in various signaling pathways, such as PI3K/Akt, NF-kappa-B and TGF-β.

2. Cell adhesion: LDHAL6B can serve as a cell adhesion molecule and participate in the interaction between cells and matrix, thus affecting the distribution and attachment of cells in tissues.

3. Cell proliferation: LDHAL6B can serve as a cell proliferation molecule, participate in the cell cycle, and promote cell proliferation.

4. Apoptosis: LDHAL6B can serve as a molecule of apoptosis, participate in apoptosis, and remove damaged or abnormal cells.

5. Immune response: LDHAL6B can serve as an immune response molecule, participating in the recognition and activation of immune cells, thereby participating in the immune response.

Pharmacological significance of LDHAL6B

As an important biomolecule, LDHAL6B plays an important role in the fields of tumors, liver diseases, heart disease, and neurological diseases. Therefore, LDHAL6B has become a drug target of great concern. Many studies have shown that inhibitors of LDHAL6B can inhibit the development of tumors, liver disease, heart disease and neurological diseases. In addition, some studies have shown that inhibitors of LDHAL6B can improve patient survival rates.

in conclusion

As an important biomolecule, LDHAL6B plays an important role in the fields of tumors, liver diseases, heart disease, and neurological diseases. Therefore, LDHAL6B has become a drug target of great concern.

Protein Name: Lactate Dehydrogenase A Like 6B

The "LDHAL6B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LDHAL6B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets